We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI Coils Awarded for Innovation

By MedImaging staff writers
Posted on 13 Feb 2007
A line of endorectal magnetic resonance imaging (MRI) coils, called eCoil, has received the Frost & Sullivan product differentiation innovation award for offering "unprecedented” MRI of prostate, colon, and cervix regions. More...


"The eCoils offerings are the market leading internal coils for pelvic imaging including prostate, colon, and cervix, used for both 1.0T and 1.5T MR scanners,” stated Frost & Sullivan research analyst Subha B. Basu, from Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company. "The eCoil line has also expanded into the 3.0T scanner market to include the first prostate coils for the fast-growing 3.0T segment.”

Frost & Sullivan presents the award yearly to a company that has demonstrated the ability to develop and/or advance products with more innovative capabilities than competing vendors and products. This award notes expectations that eCoil product line, manufactured by Medrad, Inc. (Indianola, PA, USA), will make a significant contribution to healthcare through product performance and rate of technical change.

The eCoil line was designed to produce small field-of-view (FOV) and high spatial resolution, sensitivity, and specificity in images of the pelvic region. A high signal-to-noise ratio is achieved by enabling clinicians to position the signal-amplifying elements of the coil closer to the anatomy than is possible with conventional surface coils, resulting in very accurate imaging.

The eCoil line consists of disposable endorectal probes that are interfaced using various auto-tuning devices compatible with major manufacturers' MR scanners. A specific design of probe is available for the anatomic differences of prostate, colorectal, and cervical regions.

Medrad is a developer of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, the company's product range includes a comprehensive line of vascular injection systems, MR surface coils, and patient care products, and equipment services.



Related Links:
Medrad
Frost & Sullivan

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Blood Bank Refrigerator
MBR-705GR-PE
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.